Website Logo

Press

Keep up-to-date with relevant news, important announcements and key market insights.

READ MORE
FEATURED

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Download here

Press Release

About Bionical Emas

Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

READ MORE

Bionical Emas introduces Veeva Vault Safety

News

READ MORE

Bionical Emas launches Managed Access Program for JZP 458 – a recombinant Crisantaspase produced in Pseudomonas fluorescens

Press Release

READ MORE

Webinar: 24 Hours of Rare

Resource

READ MORE

Webinar: Bionical Emas Panel: Challenges and Solutions Through Real World Data Capture in EAP

Resource

READ MORE

Webinar: Key Patient Focused Considerations to Successfully Operationalize an EAP

Resource

READ MORE

Fact Sheet: Pharmacovigilance

Resource

READ MORE

Fact Sheet: A guide to the Development Safety Update Report (DSUR)

Resource

READ MORE

Fact Sheet: Benefits of Bionical Emas – Phase 1 Services

Resource

READ MORE

Webinar: The importance of Real World Data Collection through Early Access Programs

Resource

READ MORE

Webinar: A Patient Panel, discussing Access Challenges with their unique patient perspectives

Resource

READ MORE

Webinar: Metabolic Support UK Annual Conference

Resource

READ MORE

G1 Therapeutics, Inc and Bionical Emas Launch Expanded Access Program in the United States

Press Release

2 / 3